Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

BACKGROUND: European travellers to endemic countries are at risk of malaria and may be affected by a different range of co-morbidities than natives of endemic regions. The safety profile, especially cardiac issues, of artenimol (previously dihydroartemisinin)–piperaquine (APQ) Eurartesim(®) during t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vignier, Nicolas, Bouchaud, Olivier, Angheben, Andrea, Bottieau, Emmanuel, Calleri, Guido, Salas-Coronas, Joaquín, Martin, Charlotte, Ramos, José Manuel, Mechain, Matthieu, Rapp, Christophe, Nothdurft, Hans-Dieter, Velasco, Maria, Bardají, Azucena, Rojo-Marcos, Gerardo, Visser, Leo G., Hatz, Christoph, Bisoffi, Zeno, Jelinek, Tomas, Duparc, Stephan, Bourhis, Yann, Tommasini, Silva, Iannucelli, Maurizio, Bacchieri, Antonella, Mattera, Giovan Giuseppe, Merlo Pich, Emilio, Behrens, Ronald H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105939/
https://www.ncbi.nlm.nih.gov/pubmed/33964945
http://dx.doi.org/10.1186/s12936-021-03750-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105939/
https://www.ncbi.nlm.nih.gov/pubmed/33964945
http://dx.doi.org/10.1186/s12936-021-03750-x

Ejemplares similares